Insmed Incorporated (INSM) financials

Biotechnology · NASDAQ · Health Care

$112.58 +0.89% Close Oct 30, 2026 Live

Insmed revenue and earnings by year

Insmed's revenue was $606 million in the fiscal year to December 31, 2025, up 66.7% from the year before. Net income was -$1.28 billion, -210.5% of revenue. Since the fiscal year to December 31, 2018, revenue has grown 80.2% a year on average.

RevenueNet income
-$1.00B$0
20182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 8 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue0.610.360.310.250.190.160.140.01
Revenue growth66.7%19.2%24.4%30.2%14.6%20.5%1287.6%—
Gross profit0.480.280.240.190.140.120.110.01
Gross margin79.7%76.4%78.5%77.5%76.6%75.7%82.3%75.4%
Operating income-1.25-0.88-0.71-0.46-0.38-0.27-0.24-0.31
Operating margin-205.6%-241.5%-232.5%-186.4%-199.0%-161.3%-172.4%-3124.9%
Net income-1.28-0.91-0.75-0.48-0.43-0.29-0.25-0.32
Net margin-210.5%-251.2%-245.6%-196.3%-230.6%-178.9%-186.4%-3297.2%
Diluted EPS-$6.42-$5.57-$5.34-$3.91-$3.88-$3.01-$3.01-$4.22
Free cash flow-0.97-0.71-0.55-0.41-0.37-0.23-0.29-0.27

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open INSM in Markets.

How Insmed makes money

Revenue by segment in the quarter to September 30, 2026, as the company reports it.

SegmentRevenueShare
BRINSUPRI$400M76.3%
ARIKAYCE$124M23.7%

See also: INSM returns

No forecast, no recommendation. This page describes Insmed Incorporated from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.